The PI3K-Akt-mTOR and associated signaling pathways as molecular drivers of immune-mediated inflammatory skin diseases: update on therapeutic strategy using …

T Roy, ST Boateng, MB Uddin, S Banang-Mbeumi… - Cells, 2023 - mdpi.com
The dysregulated phosphatidylinositol-3-kinase (PI3K)-Akt-mammalian target of rapamycin
(mTOR) signaling pathway has been implicated in various immune-mediated inflammatory …

Global Guidelines in Dermatology Mapping Project (GUIDEMAP), a systematic review of atopic dermatitis clinical practice guidelines: are they clear, unbiased …

BWM Arents, EJ van Zuuren… - British Journal of …, 2022 - academic.oup.com
Abstract Background Clinical practice guidelines (CPGs) are essential in delivering optimum
healthcare, such as for atopic dermatitis (AD), a highly prevalent skin disease. Although …

Mesenchymal stem cells and atopic dermatitis: a review

SRT Daltro, CS Meira, IP Santos… - Frontiers in cell and …, 2020 - frontiersin.org
Mesenchymal stem/stromal cells (MSCs) are stromal-derived non-hematopoietic progenitor
cells that reside in and can be expanded from various tissues sources of adult and neonatal …

Healthcare disparities in atopic dermatitis in Latin America: a narrative review

J Sánchez, IS Ale, MV Angles, GG Fogelbach… - Dermatology and …, 2023 - Springer
Introduction Atopic dermatitis (AD) is a chronic, pruritic skin disease caused by a mixture of
genetic, immunological, and environmental factors, characterized by periods of inflammation …

Recommendations for emollients, bathing and topical corticosteroids for the treatment of atopic dermatitis: a systematic review of guidelines

KF Van Halewijn, T Lahnstein, AM Bohnen… - European Journal of …, 2022 - Springer
Background Emollients and topical corticosteroids are key elements in treating atopic
dermatitis. However, there is variation in treatment recommendations as stated in …

Progression of mycosis fungoides after treatment with dupilumab: A case report.

D Miyashiro, AG Vivarelli, F Gonçalves… - Dermatologic …, 2020 - search.ebscohost.com
Mycosis fungoides (MF) is the most common cutaneous T-cell lymphoma (CTCL). Multiple
skin biopsies on different lesions (including a tumor on the left arm) showed spongiotic and …

[HTML][HTML] Consensus on the therapeutic management of atopic dermatitis‒Brazilian Society of Dermatology: an update on phototherapy and systemic therapy using e …

RL Orfali, D Lorenzini, A Bressan… - Anais brasileiros de …, 2023 - SciELO Brasil
This publication is an update of the “Consensus on the therapeutic management of atopic
dermatitis-Brazilian Society of Dermatology” published in 2019, considering the novel …

The unmet needs in atopic dermatitis control in Latin America: a multidisciplinary expert perspective

J Sanchez, I Cherrez-Ojeda, C Galvan, E Garcia… - Dermatology and …, 2021 - Springer
Introduction Adoption of control tools for atopic dermatitis (AD) in Latin America (LA) is
currently very limited. Clinical assessment tools represent a practical method to measure the …

Guidelines for the Management of Atopic Dermatitis in Children: A Systematic Review

Q Wang, L Liu, S Gao, S Su - International Archives of Allergy and …, 2023 - karger.com
Introduction: Numerous guidelines have been published for atopic dermatitis management
in children in recent years. To date, the quality of the newest guidelines has not been …

Atopic dermatitis in Latin America: considerations on epidemiology, clinical and laboratory features, ethnic/racial variations, and therapeutic management

GB Soares, RL Orfali, BL Averbach… - Journal of clinical …, 2023 - mdpi.com
Latin America (LA) encompasses about 8.5% of the world's population, exhibits ethnic/racial
heterogeneity and social inequality. We hereby present a 20-year literature review (2004 …